Error: Could not add to watchlist. X

Mast Therapeutics Inc

+ Watchlist
ANX:US
Ticker Change
ANX:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
0.733
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Mast Therapeutics Inc. is a biopharmaceutical company leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers for serious or life-threatening diseases with significant unmet needs.
ADDRESS
12390 El Camino Real
Suite 150
San Diego, CA 92130
United States
PHONE
1-858-552-0866
  • Brian M Culley
    Chief Executive Officer
  • Brandi L Roberts
    Senior VP/CFO
  • Edwin L Parsley "Ed"
    Senior VP/Chief Medical Ofcr
  • Gregory D Gorgas
    Senior VP:Commercial
  • R Martin Emanuele
    Senior VP:Development
Show More